HomeCompareBAYRY vs DIVO

BAYRY vs DIVO: Dividend Comparison 2026

BAYRY yields 0.26% · DIVO yields 6.49%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DIVO wins by $11.0K in total portfolio value
10 years
BAYRY
BAYRY
● Live price
0.26%
Share price
$11.48
Annual div
$0.03
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$19.7K
Annual income
$0.03
Full BAYRY calculator →
DIVO
DIVO
● Live price
6.49%
Share price
$44.85
Annual div
$2.91
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$981.68
Full DIVO calculator →

Portfolio growth — BAYRY vs DIVO

📍 DIVO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBAYRYDIVO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BAYRY + DIVO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BAYRY pays
DIVO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BAYRY
Annual income on $10K today (after 15% tax)
$22.21/yr
After 10yr DRIP, annual income (after tax)
$0.03/yr
DIVO
Annual income on $10K today (after 15% tax)
$552.00/yr
After 10yr DRIP, annual income (after tax)
$834.43/yr
At 15% tax rate, DIVO beats the other by $834.40/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BAYRY + DIVO for your $10,000?

BAYRY: 50%DIVO: 50%
100% DIVO50/50100% BAYRY
Portfolio after 10yr
$25.2K
Annual income
$490.85/yr
Blended yield
1.95%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BAYRY right now

BAYRY
Analyst Ratings
1
Buy
2
Hold
Consensus: Hold
Altman Z
0.9
Piotroski
5/9
DIVO
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BAYRY buys
0
DIVO buys
0
No recent congressional trades found for BAYRY or DIVO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBAYRYDIVO
Forward yield0.26%6.49%
Annual dividend / share$0.03$2.91
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%0%
Portfolio after 10y$19.7K$30.7K
Annual income after 10y$0.03$981.68
Total dividends collected$26.00$8.2K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: BAYRY vs DIVO ($10,000, DRIP)

YearBAYRY PortfolioBAYRY Income/yrDIVO PortfolioDIVO Income/yrGap
1← crossover$10,713$13.07$11,349$649.42$636.00DIVO
2$11,470$6.54$12,833$688.83$1.4KDIVO
3$12,276$3.27$14,459$727.90$2.2KDIVO
4$13,137$1.64$16,238$766.49$3.1KDIVO
5$14,057$0.82$18,179$804.47$4.1KDIVO
6$15,041$0.41$20,293$841.71$5.3KDIVO
7$16,094$0.20$22,591$878.14$6.5KDIVO
8$17,221$0.10$25,087$913.65$7.9KDIVO
9$18,427$0.05$27,791$948.18$9.4KDIVO
10$19,717$0.03$30,718$981.68$11.0KDIVO

BAYRY vs DIVO: Complete Analysis 2026

BAYRYStock

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc.; strategic research partnership with University of Oxford to develop novel gynecological therapies; and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.

Full BAYRY Calculator →

DIVOETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →
📬

Get this BAYRY vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BAYRY vs SCHDBAYRY vs JEPIBAYRY vs OBAYRY vs KOBAYRY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.